SABCS: Interrupting Endocrine Therapy Does Not Pose Breast Cancer Recurrence Risk
Findings seen among young women with early-stage, hormone receptor-positive breast cancer desiring pregnancy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.